Are you Dr. Sloan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 75 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
505 Elm St Ne
Albuquerque, NM 87102Phone+1 505-727-4919Fax+1 505-727-4915
Summary
- Dr. John Sloan, MD is a board certified preventive medicine physician in Albuquerque, New Mexico. He is currently licensed to practice medicine in New Mexico, California, and Illinois. He is affiliated with Heart Hospital of New Mexico at Lovelace Medical Center, Lovelace UNM Rehabilitation Hospital, and Kindred Hospital-Albuquerque.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Physical Medicine and Rehabilitation, 1989 - 1992
- University of WashingtonFellowship, Surgical Critical Care, 1987 - 1988
- University of WashingtonResidency, Surgery, 1985 - 1987
- Michael Reese Hospital and Medical CenterResidency, Surgery, 1983 - 1985
- University of Washington School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1989 - Present
- NM State Medical License 1992 - 2026
- IL State Medical License 1983 - 1985
- American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation
- American Board of Physical Medicine and Rehabilitation Brain Injury Medicine
- American Board of Preventive Medicine Occupational Medicine
- American Board of Preventive Medicine Public Health & General Preventive Medicine
Publications & Presentations
PubMed
- 9 citationsA Highly Sensitive and Drug-Tolerant Anti-Drug Antibody Screening Assay for Ixekizumab using Affinity Capture ElutionTalia M. Muram, John H. Sloan, Jana S. Chain, Wendy J. Komocsar, Bruce I. Meiklejohn
The Journal of Investigative Dermatology. 2016-07-01 - 28 citationsAffinity capture elution bridging assay: A novel immunoassay format for detection of anti-therapeutic protein antibodies.Yan Q. Chen, Thomas G. Pottanat, Quincy L. Carter, Jason S. Troutt, Robert J. Konrad
Journal of Immunological Methods. 2016-04-01 - 65 citationsEndogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetesJennifer S. ten Kulve, Dick J. Veltman, Liselotte van Bloemendaal, Frederik Barkhof, Carolyn F. Deacon
Diabetologia. 2015-09-18
Professional Memberships
- Member